Skip to main content
Premium Trial:

Request an Annual Quote

EdgeBio Receives CLIA Certification, Launches Clinical Exome Test

Premium

EdgeBio has received CLIA certification for its next-generation sequencing operations and has launched a clinical exome test.

The company has been offering next-gen sequencing services and sequencing products since 2008, and currently offers sequencing services on Illumina's HiSeq, Life Technologies' SOLiD 4, and the Ion Torrent PGM.

"For the past three years we have been building expertise in both the generation and analysis of data via NGS in a research setting," CEO Dean Gaalaas said in a statement. "Receiving CLIA certification now allows us to leverage this expertise to help clinicians better diagnose and treat their patients."

EdgeBio joins a number of commercial and academic laboratories offering clinical exome tests, including Ambry Genetics; the University of California, Los Angeles; Washington University's School of Medicine; and Emory University (CSN 3/7/2012, CSN 2/29/2012, CSN 3/21/2012).

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.